financetom
Business
financetom
/
Business
/
Coca-Cola gears up for IPO of $8 billion African bottling arm, Bloomberg reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Coca-Cola gears up for IPO of $8 billion African bottling arm, Bloomberg reports
Apr 29, 2024 10:21 AM

(Reuters) -Coca-Cola is gearing up for a potential initial public offering (IPO) of its African bottling business as soon as next year, Bloomberg News reported on Monday, citing people familiar with the matter.

It may seek a valuation of more than $8 billion for the business, the report said, adding that the deliberations were at an early stage and the offering details could change.

In 2022, Coca-Cola had delayed plans of an estimated $3 billion IPO of the African bottling unit, Coca-Cola Beverages Africa (CCBA), due to turbulence in the market mainly rising from the Russia-Ukraine war, which had resulted in shaky investor confidence and a dry spell for IPOs globally.

The company in 2021 had said it was planning to list CCBA in 18 months, depending on market conditions, with primary listing in Amsterdam and a secondary listing on the Johannesburg Stock Exchange (JSE).

If listed, the flotation of the division would have been the biggest on the JSE since at least 2016 and a major boost for the flagging index.

The company did not immediately respond to a Reuters request for comment.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-BioAge Labs Announces Pricing Of Upsized Initial Public Offering Of 11 Million Shares At $18.00 Per Share
BRIEF-BioAge Labs Announces Pricing Of Upsized Initial Public Offering Of 11 Million Shares At $18.00 Per Share
Sep 25, 2024
Sept 25 (Reuters) - * BIOAGE LABS ANNOUNCES PRICING OF UPSIZED INITIAL PUBLIC OFFERING * BIOAGE LABS, INC- ANNOUNCED PRICING OF UPSIZED INITIAL PUBLIC OFFERING OF 11 MILLION SHARES AT A PUBLIC OFFERING PRICE OF $18.00 PER SHARE Source text for Eikon: ...
Weight-loss drug developer BioAge raises $198 mln in US IPO
Weight-loss drug developer BioAge raises $198 mln in US IPO
Sep 25, 2024
Sept 25 (Reuters) - BioAge Labs has raised $198 million after pricing its upsized U.S. initial public offering at the midpoint of the range at $18 per share, the weight-loss drug developer said on Wednesday. ...
Market Chatter: Oracle-backed Ampere Reportedly Considering Sale
Market Chatter: Oracle-backed Ampere Reportedly Considering Sale
Sep 25, 2024
08:53 AM EDT, 09/19/2024 (MT Newswires) -- Oracle-backed (ORCL) Ampere Computing is exploring a potential sale, Bloomberg reported Thursday, citing people with knowledge of the matter. The chip designer has been fielding interest from potential suitors with the help of a financial advisor, according to the report. Discussions are ongoing and the company could remain independent, though it is no...
Oppenheimer Holdings to Redeem $113 Million of Senior Notes Due 2025
Oppenheimer Holdings to Redeem $113 Million of Senior Notes Due 2025
Sep 25, 2024
10:40 AM EDT, 09/19/2024 (MT Newswires) -- Oppenheimer Holdings ( OPY ) said Thursday it sent a notice to holders of its 5.50% senior secured notes due 2025, indicating its intent to redeem about $113.1 million on Oct. 10. The redemption price will be 100% of the principal amount, plus any accrued and unpaid interest, the company said. Once the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved